The COVOSMIA-19 trial: Preliminary application of the Singapore smell and taste test to objectively measure smell and taste function with COVID-19
- PMID: 34848929
- PMCID: PMC8612753
- DOI: 10.1016/j.foodqual.2021.104482
The COVOSMIA-19 trial: Preliminary application of the Singapore smell and taste test to objectively measure smell and taste function with COVID-19
Abstract
Sudden loss of smell and/or taste has been identified as an early symptom of SARS-CoV-2 2019 (COVID-19) infection, and presents an effective target for prompt self-isolation and reducing community spread. The current study sought to develop and test a novel, rapid, self-administered test to objectively measure smell and taste losses associated with COVID-19, and administered self-report questionnaires to characterise symptoms associated with COVID-19 in Singapore. Participants (N = 99) completed questionnaires to record recent changes in smell and taste ability. This was followed by the 'Singapore Smell and Taste Test' (SSTT), a personal, objective testing kit for daily self-assessment of smell and taste function at their place of residence. Seventy-two recruited participants were confirmed as COVID-19 positive at baseline, of which 58 completed the SSTT at home. Of these, 36.2% had objectively measured smell and/or taste loss. The SSTT measures of smell and taste function were positively associated with participants' self-reported smell and taste acuity, and rated smell intensity of 6 common household items. This study presents the first application of the SSTT as a rapid, cost-effective, objective tool to self-monitor smell and taste function in a residential setting, and ensures comparability across individuals through the use of standardised stimuli. The SSTT has potential for future application in populations with limited access to formal COVID-19 testing as a self-administered objective method to monitor sudden changes in smell and taste, and to prompt early self-isolation, in order to reduce community transmission of COVID-19.
Keywords: Ageusia; Anosmia; COVID-19; COVID-19, Coronavirus disease 2019; Gustatory dysfunction; Olfactory dysfunction; PCR, Polymerase Chain Reaction; SARS-CoV-2; SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2; SNOT-22, 22-item Sino-Nasal Outcome test; SSTQ, The Singapore Smell and Taste Questionnaire; SSTT, The Singapore Smell and Taste Test; VAS, Visual Analogue Scale.
© 2021 The Author(s).
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures



Similar articles
-
Evaluating the Onset, Severity, and Recovery of Changes to Smell and Taste Associated With COVID-19 Infection in a Singaporean Population (the COVOSMIA-19 Trial): Protocol for a Prospective Case-Control Study.JMIR Res Protoc. 2020 Dec 31;9(12):e24797. doi: 10.2196/24797. JMIR Res Protoc. 2020. PMID: 33351775 Free PMC article.
-
Covid-19 affects taste independent of taste-smell confusions: results from a combined chemosensory home test and online survey from a large global cohort.Chem Senses. 2023 Jan 1;48:bjad020. doi: 10.1093/chemse/bjad020. Chem Senses. 2023. PMID: 37350646 Free PMC article.
-
Simultaneously complete but not partial taste and smell losses were associated with SARS-CoV-2 infection.Int J Infect Dis. 2021 May;106:329-337. doi: 10.1016/j.ijid.2021.03.083. Epub 2021 Apr 2. Int J Infect Dis. 2021. PMID: 33819604 Free PMC article.
-
Sudden onset, acute loss of taste and smell in coronavirus disease 2019 (COVID-19): a systematic review.Acta Odontol Scand. 2020 Aug;78(6):467-473. doi: 10.1080/00016357.2020.1787505. Epub 2020 Aug 7. Acta Odontol Scand. 2020. PMID: 32762282
-
Potential pharmacologic treatments for COVID-19 smell and taste loss: A comprehensive review.Eur J Pharmacol. 2021 Dec 5;912:174582. doi: 10.1016/j.ejphar.2021.174582. Epub 2021 Oct 19. Eur J Pharmacol. 2021. PMID: 34678243 Free PMC article. Review.
Cited by
-
Prevalence of taste and smell dysfunction in mild and asymptomatic COVID-19 patients during Omicron prevalent period in Shanghai, China: a cross-sectional survey study.BMJ Open. 2023 Mar 21;13(3):e067065. doi: 10.1136/bmjopen-2022-067065. BMJ Open. 2023. PMID: 36944468 Free PMC article.
-
Olfactory Function and Olfactory Disorders.Laryngorhinootologie. 2023 May;102(S 01):S67-S92. doi: 10.1055/a-1957-3267. Epub 2023 May 2. Laryngorhinootologie. 2023. PMID: 37130532 Free PMC article.
References
-
- American Academy of Otolaryngology-Head and Neck Surgery. (2020). Anosmia, Hyposmia, and Dysgeusia Symptoms of Coronavirus Disease. https://www.entnet.org/content/aao-hns-anosmia-hyposmia-and-dysgeusia-sy....
-
- Bagheri S.H., Asghari A., Farhadi M., Shamshiri A.R., Kabir A., Kamrava S.K., Jalessi M., Mohebbi A., Alizadeh R., Honarmand A.A., Ghalehbaghi B., Salimi A., Firouzabadi F.D. Coincidence of COVID-19 epidemic and olfactory dysfunction outbreak in Iran. Medical Journal of the Islamic Republic of Iran. 2020;34(1)(62):1–7. doi: 10.34171/mjiri.34.62. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous